Clinical Trial Update: IRIS-BioFreedom Cohort in the IRIS-DES Registry

View source ↗

Summary

The IRIS-BioFreedom cohort within the IRIS-DES registry has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Stenosis | Status: TERMINATED